Cargando…
Mifepristone Derivative FZU-00,003 Suppresses Triple-negative Breast Cancer Cell Growth partially via miR-153-KLF5 axis
Triple-negative breast cancer (TNBC) is one of the most malignant breast cancers lacking targeted therapeutics currently. We recently reported that mifepristone (MIF), a drug regularly used for abortion, suppresses TNBC cell growth by inhibiting KLF5 expression via inducing miR-153. However, its ant...
Autores principales: | Liu, Rong, Chen, Haijun, Zhao, Ping, Chen, Chuan-Huizi, Liang, Huichun, Yang, Chuanyu, Zhou, Zhongmei, Zhi, Xu, Liu, Suling, Chen, Ceshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990921/ https://www.ncbi.nlm.nih.gov/pubmed/32025209 http://dx.doi.org/10.7150/ijbs.39491 |
Ejemplares similares
-
Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression
por: Liu, Rong, et al.
Publicado: (2016) -
miR-153 inhibits the migration and the tube formation of endothelial cells by blocking the paracrine of angiopoietin 1 in breast cancer cells
por: Liang, Huichun, et al.
Publicado: (2018) -
Pyrrolo [3,4-b]-quinolin-9-amine compound FZU-0038-056 suppresses triple-negative breast cancer partially through inhibiting the expression of Bcl-2
por: Wang, Danping, et al.
Publicado: (2020) -
Angiopoietin-1 promotes triple-negative breast cancer cell proliferation by upregulating carboxypeptidase A4: ANG1-CPA4 axis promotes TNBC progression
por: Liu, Xue, et al.
Publicado: (2023) -
Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation
por: Shi, Peiguo, et al.
Publicado: (2017)